Bean, Scott

Christoforidis, John

La Perle, Krista

Pierce, Jordan

Pratt, Cedric

Ricketts, Robert

Wells, Michael

Zhang, Xiaoli

Clinical Ophthalmology

English

PubMed

John Christoforidis

null Ricketts

null Pratt

null Pierce

null Bean

null Wells

null Zhang

null LaPerle

Crossref

The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

A review on bevacizumab and surgical wound healing: an important warning to all surgeons. Ann Plast Surg.

al; for the International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States,

Ambulatory surgery in the United States,

Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer.

Angiogenesis: Regulators and clinical applications. Biochem Pharmacol.

Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation.

Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer.

Cutaneous wound healing.

Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Final efficacy results for bevacizumab plus standard first-line chemotherapies in patients with metastatic colorectal cancer: first BEAT. J Clin Oncol. 2008; 26(Suppl 15):abstract 4025.

for the Eye Diseases Prevalence Research Group: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol.

for the Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol.

GJ; for the CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

Healing of partial thickness porcine skin wounds in a liquid environment. J Surg Res.

High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor. Eur Urol.

Histologic characterization of vaginal vs abdominal surgical wound healing in a rabbit model. Wound Repairs Regen.

Hypoxemic resuscitation after hemorrhagic shock is accompanied by reduced serum levels of angiopoietin-2.

Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.

Initial Safety Report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer (BEAT).

Intraclass correlations: Uses in assessing rater reliability. Psychol Bull.

Intricacies of bevacizumab-induced toxicities and their management.

Macugen (pegaptanib sodium injection) product information. RX List. The Internet Drug List. Available at: http://www.rxlist.com/macugendrug.htm.

Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol.

Mechanism of action and in-vivo role of platelet-derived growth factor. Physiol Rev.

New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer? Arch Ophthalmol.

Normoxic wound fluid contains high levels of vascular endothelial growth factor. Ann Surg.

Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes. Invest Ophthalmol Vis Sci.

Preclinical pharmacokinetics of ranibizumab after a single intravitreal administration. Invest Ophthalmol Vis Sci.

Preclinical pharmacokinetics, interspecies scaling and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor. J Pharmacol Exp Ther.

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor; systematic review and meta-analysis.

Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response. Anticancer Drugs.

Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med.

Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab.

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study.

Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumabbased therapy.

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.

VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

Wound dehiscence or failure to heal following venous access port placement in patients receiving bevacizumab therapy.

Wound Healing and Wound Infection: Theory and Surgical Practice.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3261691

The effect of intravitreal anti-VEGF agents on peripheral wound healing in a rabbit model

Abstract

Similar works

Full text

Available Versions

Crossref